Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal

💡Analysis & Context
Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21 billion acquisition of cancer-screening company E Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21 billion acquisition of cancer-screening company E Monitor developments in Abbott for further updates.
📋 Quick Summary
Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21
Original Source:
Read full article at sourceHelp us improve this article. Share your feedback and suggestions.


